Bearish flow noted in Amgen (AMGN) with 6,679 puts trading, or 3x expected. Most active are Nov-24 280 puts and Nov-24 355 calls, with total volume in those strikes near 5,700 contracts. The Put/Call Ratio is 3.64, while ATM IV is up over 1 point on the day. Earnings are expected on October 30th.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMGN:
- Amgen to launch U.S. Eylea biosimilar, Reuters reports
- Regeneron price target lowered to $1,050 from $1,200 at Wells Fargo
- RBC would buy Regeneron on weakness with biosimilar Eylea priced in
- Morgan Stanley names Amgen ‘catalyst-driven idea’ into Phase 2 MariTide data
- Amgen price target raised to $383 from $381 at TD Cowen